Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bei-Zhong Liu MD"'
Autor:
Chun-Guang Wang MMed, Liang Zhong MMed, Yong-Li Liu BMed, MMB, Xue-Jun Shi MMed, Long-Qin Shi BN, Li Zeng MMed, Bei-Zhong Liu MD
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
The BCR-ABL kinase inhibitor, imatinib mesylate, is the front-line treatment for chronic myeloid leukemia, but the emergence of imatinib resistance has led to the search for alternative drug treatments. There is a pressing need, therefore, to develop
Externí odkaz:
https://doaj.org/article/c0de4f8ffed14bdeb358923c977e743f
